Ryan D Maynard Insider Trading
Get free email notifications about insider trading for Ryan D Maynard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ryan D Maynard. Ryan D Maynard is a EVP & CFO in RIGEL PHARMACEUTICALS INC ($RIGL) and a VP Finance, Acting CFO in RIGEL PHARMACEUTICALS INC ($RIGL) and a Director in Lion Biotechnologies, Inc. ($LBIO).
Address: RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO 94306-2155 CA
Companies in which Ryan D Maynard is an Insider
IOVANCE BIOTHERAPEUTICS, INC.
Trading Symbol: IOVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ryan D Maynard: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 10 2020
$IOVA Market Capitalization: $437.71M
$IOVA Previous Close: $7.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RIGEL PHARMACEUTICALS INC
Trading Symbol: RIGLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ryan D Maynard: EVP & CFO, VP Finance, Acting CFO
Holdings: 100,000 shares
Current Value: $245,000
Latest Transaction: Nov 07 2017
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Ryan D Maynard
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2020 | IOVA | IOVANCE BIOTHERAPE ... | Maynard Ryan D | Director | Option Exercise | A | 32.17 | 35,000 | 1,125,950 | 35,000 | |
Jun 11 2019 | IOVA | IOVANCE BIOTHERAPE ... | Maynard Ryan D | Director | Option Exercise | A | 19.93 | 35,000 | 697,550 | 35,000 | |
Jul 19 2018 | IOVA | IOVANCE BIOTHERAPE ... | Maynard Ryan D | Director | Option Exercise | A | 14.45 | 35,000 | 505,750 | 35,000 | |
Nov 07 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 2.14 | 100,000 | 214,000 | 75,000 | |
Nov 07 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 3.90 | 100,000 | 390,000 | 0 | 100 K to 0 (-100.00 %) |
Nov 07 2017 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 2.14 | 100,000 | 214,000 | 100,000 | 0 to 100 K |
Jun 05 2017 | LBIO | Lion Biotechnologi ... | Maynard Ryan D | Director | Option Exercise | A | 5.45 | 35,000 | 190,750 | 35,000 |